Achalasia subtype differences based on clinical symptoms, radiographic findings, and stasis scores.
نویسنده
چکیده
The article by Meillier et al. included in this issue evaluated the clinical differences between achalasia subtypes based on symptoms, esophagram, and a new esophageal stasis score measured with high-resolution impedance manometry (HRIM). The findings of interest in that study on 108 patients are: 1) clinical symptoms did not aid in distinguishing the different achalasia subtypes, with the exception of vomiting, which was more common in subtype I; 2) the degree of esophageal dilation, obtained through measuring the largest diameter of the distal esophagus in the esophagram, was significantly less in subtype III, but no difference was found in subtypes I and II, and 3) the stasis scores of the three subtypes showed no differences. Despite the limitations inherent in the retrospective design of the study and the small number of patients with subtype I, it demonstrated the impossibility of classifying achalasia subtypes through symptom questionnaires or parameters of esophageal stasis measurement. High resolution manometry is essential for establishing achalasia classification, whose prediction of treatment response results in its well-known prognostic importance. A striking aspect of the case series by Meillier et al. was the lower mean age of patients with subtype I, compared with those with subtypes II and III. Even more intriguing was the fact that the esophageal diameter was greater in subtype II achalasia than in subtype I. Previous studies led us to infer that subtype II corresponded to initial stages of achalasia and that subtype I occurred in advanced disease stages, with the characteristic important dilation of the esophageal body and retention of food remnants. The findings by Meillier et al. do not concur with that
منابع مشابه
Difference of achalasia subtypes based on clinical symptoms, radiographic findings, and stasis scores.
INTRODUCTION Three subtypes of achalasia have been defined through high-resolution esophageal manometry: subtype i shows no pressurization with swallows, subtype ii has increased isobaric panesophageal pressure, and subtype iii has distal esophageal spastic non-isobaric contractions. Studies describing the subtypes based on radiographic findings, clinical symptoms, and stasis scores are limited...
متن کاملمانومتری با قدرت تفکیک بالا در افتراق اختلالات حرکتی مری
Background: High-resolution manometer (HRM) of the esophagus has become the main diagnostic test in the evaluation of esophageal motility disorders. The development of high-resolution manometry catheters and software displays of manometry recordings in color-coded pressure plots have changed the diagnostic assessment of esophageal disease. The first step of the Chicago classification described ...
متن کاملAn Overview of Achalasia and Its Subtypes.
Achalasia is one of the most studied esophageal motility disorders. However, the pathophysiology and reasons that patients develop achalasia are still unclear. Patients often present with dysphagia to solids and liquids, regurgitation, and varying degrees of weight loss. There is significant latency prior to diagnosis, which can have nutritional implications. The diagnosis is suspected based on...
متن کاملAssociation of High-Resolution Manometry Metrics with the Symptoms of Achalasia and the Symptomatic Outcomes of Peroral Esophageal Myotomy
BACKGROUND High-resolution manometry (HRM) has improved the accuracy of manometry in detecting achalasia and has helped distinguish between clinically relevant subtypes. This study investigated whether HRM metrics correlate with the achalasia symptoms and symptomatic outcomes of peroral esophageal myotomy (POEM). METHODS Of the 30 patients who were enrolled, 25 were treated with POEM, 12 of w...
متن کاملINJECTION OF BOTULINUM TOXIN IN THE TREATMENT OF ACHALASIA: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
Our aim was to evaluate the short and long term efficacy of botulinum toxin therapy in Iranian patients with achalasia. In a randomized, double blind trial, 20 patients with achalasia, referring to Imam Khomeini Hospital, received either 80 units of botulinum toxin (BT) or placebo (PL) from 1995 to 1998. Two weeks later, the response to treatment was assessed on the basis of changes in the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Revista de gastroenterologia de Mexico
دوره 83 1 شماره
صفحات -
تاریخ انتشار 2018